TB-500
$74.99
In stockTB-500 is the commercial name of this research product; its manufacturer certificate states TB4. The scientific discussion here concerns full-length Thymosin Beta-4 (Tβ4), a 43-amino-acid actin-binding peptide. The product’s exact sequence remains unverified.
| SKU | RC-ST-TB500-10MG |
|---|---|
| Manufacturer | Strandix Peptides |
| Form | Lyophilized Powder |
| Strength | 10 mg |
| Size | 3 mL Vial |
| Reported Result | See matching batch report |
| Stock | In stock |
| Documentation Status | Client-supplied report available |
"THYMOSIN BETA-4 (TB4) SCIENTIFIC OVERVIEW — PRODUCT IDENTITY PENDING VERIFICATION
Thymosin Beta-4 (Tβ4) is a naturally occurring 43-amino-acid peptide found in many mammalian tissues. It binds monomeric actin (G-actin), contributing to the regulation of cytoskeletal organization and cell motility. Research has examined full-length Tβ4 in cellular migration, experimental wound biology, angiogenesis, inflammatory signaling, and corneal and cardiac tissue-injury models. These investigations include substantial mechanistic and preclinical work and limited indication-specific clinical investigation of particular formulations. Animal and laboratory findings do not establish effectiveness for human muscle, tendon, or injury recovery.
Storage and handling: Store unopened lyophilized blend according to the manufacturer label, protected from heat, light, and moisture. Avoid repeated temperature cycling. Do not assume that storage or reconstituted stability data for either individual component applies to the blend without product-specific validation.
Third-party testing status.
| Batch / Lot | Reported Result | Tested | Partner | Status | Document |
|---|---|---|---|---|---|
| TB10/2025-12-18-B | 99.538%; 99.542% | Dec 31, 2025 | Janoshik | Client-supplied report | View COA |